PROVENANCE is a life science boutique consulting firm specializing in aging and chronic conditions.
We help promising therapeutics and products cross the valleys of death between discovery, evidence, and market.
Our Expertise
Our main therapeutic areas address the complex health challenges of aging adults
Aging & Independence
Sarcopenia · Cognitive Impairment · Loneliness & Social Isolation (LSI)
Cardiovascular & Pulmonary
Heart Failure · COPD · Geriatric Critical Illness
Complementary & Perpendicular Medicine
Supplements & Medical Foods · Drug Repurposing · Biomodulation
Immunity & Inflammation
Urinary Tract Infections · Antibiotic Resistance · Pneumonia
Healthcare Delivery
Novel Eldercare Models · Tech Enablement · Payor Strategy
Medical Education
AI & Clinical Workforce · Decentralized & Adaptive Learning Platforms · High-Stakes Examinations
Our Services
Our Track Record
Mission-critical advisors with proven impact since 2023
Our Recent Work
Our Approach
Our work begins at the human frontline. Our analysts are also active clinicians, investigators, and faculty who run trials and work directly with regulators. We partner with clients through a highly personal, collaborative model that emphasizes mentorship, continuity, and availability.
​​
Our contracts are flexible. Some clients bring us in for a defined project, but most continue working with us long term. Thirty percent carry us on indefinite retainer, and forty percent are partnering with us across multiyear efforts that span many product life cycles.
Our Clients
We partner with:
Our Team & Network
We are a compact strikeforce made up of healthcare opinion leaders, subject matter experts, and analysts who thrive on immersive problem-solving and the challenge of translating data into mental models that give leadership teams a prescient edge in complex markets.
The core team leverages a critical mass of 50+ SMEs spanning major disciplines in healthcare, from translational research, to late stage trials, and finally to to clinical care. PI's roster of experts are attuned to early signals in science, regulation, and markets. By having boots on the ground, they anticipate disruption 12-18 months before reaching mainstream awareness.